Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.

[1]  J. Lindholt,et al.  Randomized double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion , 2001, The British journal of surgery.

[2]  Jeroen J. Bax,et al.  Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery , 2003, Circulation.

[3]  M. Henriksson,et al.  Decision‐analytical model with lifetime estimation of costs and health outcomes for one‐time screening for abdominal aortic aneurysm in 65‐year‐old men , 2005, The British journal of surgery.

[4]  Simon G. Thompson,et al.  Abdominal Aortic Aneurysm Expansion: Risk Factors and Time Intervals for Surveillance , 2004, Circulation.

[5]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[6]  J J Bax,et al.  Abdominal aortic aneurysm screening using a hand-held ultrasound device. "A pilot study". , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[7]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[8]  M. Leinonen,et al.  Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. , 2001, Journal of vascular surgery.

[9]  A. Newby,et al.  Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  RAP Scott,et al.  The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial , 2002, The Lancet.

[11]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[12]  S. Humphries,et al.  Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Libby,et al.  An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro , 2001, Circulation.

[14]  J. Powell,et al.  Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms , 2001, Circulation.

[15]  J. Powell,et al.  Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. , 1999, Circulation.

[16]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[17]  M. Thompson,et al.  HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  Robert W. Thompson,et al.  Treatment With Simvastatin Suppresses the Development of Experimental Abdominal Aortic Aneurysms in Normal and Hypercholesterolemic Mice , 2005, Annals of surgery.

[19]  J. Liao.  Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. , 2005, The American journal of cardiology.

[20]  Erik Buskens,et al.  A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. , 2004, The New England journal of medicine.

[21]  Robert W. Thompson,et al.  Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? , 2004, The Journal of clinical investigation.

[22]  R. Béliveau,et al.  Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. , 2002, Journal of vascular surgery.

[23]  A. Coats.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[24]  Viborg Aneurysm Screening Study,et al.  A comparative study of the prevalence of abdominal aortic aneurysms in the United Kingdom, Denmark, and Australia , 2001, Journal of medical screening.

[25]  N. Hagiwara,et al.  A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. , 2002, Journal of vascular surgery.

[26]  K. Bønaa,et al.  Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : The Tromsø Study. , 2001, American journal of epidemiology.

[27]  P. Investigators.  Propranolol for small abdominal aortic aneurysms: results of a randomized trial. , 2002, Journal of vascular surgery.

[28]  M. Goldacre,et al.  Trends in mortality and hospital admission rates for abdominal aortic aneurysm in England and Wales, 1979–1999 , 2005, The British journal of surgery.

[29]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[30]  K. Bønaa,et al.  Intra- and interobserver variability in ultrasound measurements of abdominal aortic diameter. The Tromsø Study. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  B. Baxter,et al.  Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. , 2002, Journal of vascular surgery.

[32]  F. Bernini,et al.  HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[33]  R. Thompson,et al.  Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. , 1996, The Journal of surgical research.

[34]  G. Moneta,et al.  Comparison of Endovascular Aneurysm Repair With Open Repair in Patients With Abdominal Aortic Aneurysm (EVAR Trial 1), 30-Day Operative Mortality Results: Randomised Controlled Trial , 2006 .